Escitalopram
These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS.<BR><BR>ESCITALOPRAM tablets, for oral use <BR>Initial U.S. Approval: 2002
Approved
Approval ID
c1945926-4638-4e42-b51c-1c152ab5c8eb
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Mar 7, 2023
Manufacturers
FDA
A-S Medication Solutions
DUNS: 830016429
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Escitslopram
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code50090-5830
Application NumberANDA078169
Product Classification
M
Marketing Category
C73584
G
Generic Name
Escitslopram
Product Specifications
Route of AdministrationORAL
Effective DateMarch 1, 2022
FDA Product Classification
INGREDIENTS (8)
HYPROMELLOSE 2910 (5 MPA.S)Inactive
Code: R75537T0T4
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
ESCITALOPRAM OXALATEActive
Quantity: 20 mg in 1 1
Code: 5U85DBW7LO
Classification: ACTIM
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT